| scholarly article | Q13442814 |
| P50 | author | Thirumala-Devi Kanneganti | Q30003976 |
| Mahesh Chemudupati | Q59612878 | ||
| John C. Byrd | Q66429603 | ||
| P2093 | author name string | Clay B Marsh | |
| Susheela Tridandapani | |||
| Amal Amer | |||
| Xiaokui Mo | |||
| Natarajan Muthusamy | |||
| Jonathan P Butchar | |||
| William E Carson | |||
| David Jarjoura | |||
| Payal Mehta | |||
| Steven E Justiniano | |||
| Kristan D Guenterberg | |||
| Sri-Vidya Kondadasula | |||
| P2860 | cites work | Bioconductor: open software development for computational biology and bioinformatics | Q21194861 |
| Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 | Q24298297 | ||
| Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
| Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets | Q28140238 | ||
| Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway | Q28216760 | ||
| Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion | Q28473308 | ||
| Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3 | Q29615598 | ||
| γ Interferon induced by S. aureus protein A augments natural killing and ADCC | Q72634741 | ||
| Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia | Q80458847 | ||
| A shift in the balance of inhibitory and activating Fcgamma receptors on monocytes toward the inhibitory Fcgamma receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis | Q81129136 | ||
| Open source software for the analysis of microarray data. | Q30908804 | ||
| CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations | Q33193071 | ||
| Improved biodistribution, tumor targeting, and reduced immunogenicity in mice with a gamma 4 variant of Campath-1H. | Q33636882 | ||
| Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines | Q33928636 | ||
| Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation. | Q34187895 | ||
| Engineered antibody Fc variants with enhanced effector function | Q34424958 | ||
| Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential | Q35015851 | ||
| The antitumoral mode of action of imiquimod and other imidazoquinolines | Q36754557 | ||
| TLR7 and TLR8 as targets in cancer therapy | Q37051014 | ||
| The antiviral activity of Toll-like receptor 7 and 7/8 agonists | Q37128716 | ||
| Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival. | Q37142173 | ||
| Pathophysiology of tumor-associated macrophages | Q37144905 | ||
| Tumor versus tumor-associated macrophages: how hot is the link? | Q37190338 | ||
| FcR gamma chain deletion results in pleiotrophic effector cell defects | Q38311129 | ||
| Human monocyte cytotoxicity to tumor cells. I. Antibody-dependent cytotoxicity | Q39501621 | ||
| Interleukin-21 enhances NK cell activation in response to antibody-coated targets | Q40265565 | ||
| Cytokine-mediated regulation of activating and inhibitory Fc gamma receptors in human monocytes. | Q40460110 | ||
| In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice. | Q41665656 | ||
| Phagocytosis mediated by three distinct Fc gamma receptor classes on human leukocytes | Q41761440 | ||
| Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine | Q41861985 | ||
| Biologic effects of gamma interferon pre-treatment followed by monoclonal antibody 17-1A administration in patients with gastrointestinal carcinoma | Q41893898 | ||
| Toll-like receptor 4 induced FcgammaR expression potentiates early onset of joint inflammation and cartilage destruction during immune complex arthritis: Toll-like receptor 4 largely regulates FcgammaR expression by interleukin 10. | Q42099354 | ||
| Immunomodulating and antiviral activities of the imidazoquinoline S-28463. | Q42556503 | ||
| Cancer antigens: immune recognition of self and altered self | Q42650335 | ||
| Fc receptors | Q44298973 | ||
| Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern | Q45043886 | ||
| Molecular analysis of expression and function of hFcgammaRIIbl and b2 isoforms in myeloid cells | Q46624202 | ||
| Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemia | Q46940974 | ||
| Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists | Q48932895 | ||
| IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10 | Q50335926 | ||
| Systemic administration of a TLR7 ligand leads to transient immune incompetence due to peripheral-blood leukocyte depletion. | Q52767186 | ||
| Anthrax lethal toxin kills macrophages in a strain-specific manner by apoptosis or caspase-1-mediated necrosis. | Q53564376 | ||
| Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS | Q67656850 | ||
| Monocyte-mediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function | Q68207879 | ||
| Direct stimulation of ADCC by cloned gamma interferon is not ablated by glucocorticoids: studies using a human monocyte-like cell line (U-937) | Q70472256 | ||
| Endotoxin priming of monocytes augments Fc gamma receptor cross-linking-induced TNF-alpha and IL-1 beta release | Q70474059 | ||
| Stimulation of phagocytosis in bone marrow-derived mouse macrophages by bacterial lipopolysaccharide: correlation with biochemical and functional parameters | Q71395796 | ||
| The type of interaction with Fc gamma R in human monocytes determines the efficiency of the generation of oxidative burst | Q72410199 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cancer immunotherapy | Q2012719 |
| toll-like receptor | Q408004 | ||
| immunotherapy | Q1427096 | ||
| P304 | page(s) | 2065-2075 | |
| P577 | publication date | 2010-03-23 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapy | |
| P478 | volume | 16 |
| Q41000160 | A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells |
| Q41072362 | Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of Acute Myeloid Leukemic cells |
| Q38056746 | Anti-tumour strategies aiming to target tumour-associated macrophages. |
| Q39192585 | Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties |
| Q38615394 | Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity |
| Q47556910 | Direct and Intestinal Epithelial Cell-Mediated Effects of TLR8 Triggering on Human Dendritic Cells, CD14+CD16+ Monocytes and γδ T Lymphocytes |
| Q37168454 | Fcγ receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies |
| Q38615360 | FcγR requirements leading to successful immunotherapy |
| Q38301125 | Granzyme B expression is enhanced in human monocytes by TLR8 agonists and contributes to antibody-dependent cellular cytotoxicity |
| Q90212766 | Harnessing the immune system via FcγR function in immune therapy: A pathway to next-gen mAbs |
| Q34698758 | Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer |
| Q33724228 | Identification of potential biomarkers of sepsis using bioinformatics analysis |
| Q42133572 | Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection |
| Q26772080 | Influence of immunoglobulin isotype on therapeutic antibody function |
| Q38736778 | Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells |
| Q38193822 | Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets? |
| Q35116211 | Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients |
| Q46050934 | Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer |
| Q54214817 | Soluble fibrinogen-like protein 2 ameliorates acute rejection of liver transplantation in rat via inducing Kupffer cells M2 polarization. |
| Q35510560 | TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy |
| Q36594664 | Toll-like Receptor 4 Ligands Down-regulate Fcγ Receptor IIb (FcγRIIb) via MARCH3 Protein-mediated Ubiquitination |
| Q36796964 | Toll-like receptor 2 ligands regulate monocyte Fcγ receptor expression and function |
Search more.